Investigation of pituitary adenylate cyclase activating polypeptide (PACAP) in human amniotic fluid samples

Tóth, Dénes and Veszprémi, Béla and Koppán, Miklós and Tamás, Andrea and Szőgyi, Donát and Brubel, Réka and Németh, József and Shams, Masha and Reglődi, Dóra (2020) Investigation of pituitary adenylate cyclase activating polypeptide (PACAP) in human amniotic fluid samples. REPRODUCTIVE BIOLOGY. ISSN 1642-431X (In Press)

Text 1-s2.0-S1642431X20302540-main.pdf Restricted to Registered users only Download (321kB) | Request a copy

Abstract

Pituitary adenylate cyclase activating polypeptide (PACAP) is a neuropeptide acting as a hormone, a neuromodulator, a neurotransmitter, a trophic factor and is involved in a variety of developmental and regenerative processes. PACAP is present in several human tissues and biological fluids. In many pathological conditions, changes in PACAP levels have been described to reflect disease progression, therefore PACAP has diagnostic value as a potential biomarker. Since PACAP has been shown to play an important role in reproductive physiology and development, it was of interest to examine whether this neuropeptide occurs in the human amniotic fluid. Amniotic fluid samples were collected between the 15-19th weeks of gestation from volunteering pregnant women undergoing amniocentesis as a prenatal diagnostic tool due to maternal age. Pathological cases were excluded after prenatal karyotype analysis. PACAP-like immunoreactivity was measured by radioimmunoassay and could be detected in all samples. The present study provides evidence for the presence of PACAP in human amniotic fluid, but determination of the exact physiological or pathological significance awaits further investigation.

Actions (login required)

Edit Item